Arii K - Search Results

1

Cisplatin treatment renders tumor cells more susceptible to attack by lymphokine-activated killer cells.

Yamaue H, Tanimura H, Noguchi K, Iwahashi M, Tsunoda T, Tani M, Tamai M, Hotta T, Mizobata S, Arii K. Yamaue H, et al. Among authors: arii k. J Clin Lab Immunol. 1991 Aug;35(4):165-70. J Clin Lab Immunol. 1991. PMID: 1668852

2

Enhancement of tumor cell susceptibility to lymphokine-activated killer cells by treatment with the streptococcal preparation OK432.

Yamaue H, Tanimura H, Tsunoda T, Iwahashi M, Tani M, Tamai M, Noguchi K, Hotta T, Arii K. Yamaue H, et al. Among authors: arii k. Biotherapy. 1992;5(1):83-93. doi: 10.1007/BF02194788. Biotherapy. 1992. PMID: 1389905

3

The promotive effect of interleukin 4 with interleukin 2 in the proliferation of tumor-infiltrating lymphocytes from patients with malignant tumor.

Tsunoda T, Tanimura H, Yamaue H, Iwahashi M, Tani M, Tamai M, Arii K, Noguchi K. Tsunoda T, et al. Among authors: arii k. Biotherapy. 1992;4(1):9-15. doi: 10.1007/BF02171704. Biotherapy. 1992. PMID: 1543654

4

In vitro augmentation of the cytotoxic activity of peripheral blood mononuclear cells and tumor-infiltrating lymphocytes by famotidine in cancer patients.

Tsunoda T, Tanimura H, Yamaue H, Iwahashi M, Tani M, Tamai M, Arii K, Noguchi K. Tsunoda T, et al. Among authors: arii k. Int J Immunopharmacol. 1992 Jan;14(1):75-81. doi: 10.1016/0192-0561(92)90107-v. Int J Immunopharmacol. 1992. PMID: 1582736

5

In vitro generation of activated natural killer cells and cytotoxic macrophages with lentinan.

Tani M, Tanimura H, Yamaue H, Iwahashi M, Tsunoda T, Tamai M, Noguchi K, Arii K. Tani M, et al. Among authors: arii k. Eur J Clin Pharmacol. 1992;42(6):623-7. doi: 10.1007/BF00265926. Eur J Clin Pharmacol. 1992. PMID: 1623902

6

Augmentation of cytotoxic activity by combination with interleukin 2 and interferon gamma.

Tsunoda T, Tanimura H, Yamaue H, Iwahashi M, Tani M, Tamai M, Noguchi K, Arii K, Hotta T. Tsunoda T, et al. Among authors: arii k. Nihon Geka Hokan. 1991 Nov 1;60(6):396-405. Nihon Geka Hokan. 1991. PMID: 1820012

7

Chemosensitivity testing with highly purified fresh human tumour cells with the MTT colorimetric assay.

Yamaue H, Tanimura H, Tsunoda T, Tani M, Iwahashi M, Noguchi K, Tamai M, Hotta T, Arii K. Yamaue H, et al. Among authors: arii k. Eur J Cancer. 1991;27(10):1258-63. doi: 10.1016/0277-5379(91)90093-s. Eur J Cancer. 1991. PMID: 1835595

8

Polysaccharide preparation PSK augments the proliferation and cytotoxicity of tumor-infiltrating lymphocytes in vitro.

Noguchi K, Tanimura H, Yamaue H, Tsunoda T, Iwahashi M, Tani M, Mizobata S, Hotta T, Arii K, Tamai M, et al. Noguchi K, et al. Among authors: arii k. Anticancer Res. 1995 Mar-Apr;15(2):255-8. Anticancer Res. 1995. PMID: 7762991

9

In vitro augmentation of cytotoxic activity of peripheral blood lymphocytes and spleen cells of cancer patients by ubenimex.

Iwahashi M, Tanimura H, Yamaue H, Tsunoda T, Tani M, Noguchi K, Mizobata S, Tamai M, Hotta T, Arii K, et al. Iwahashi M, et al. Among authors: arii k. Anticancer Res. 1994 Jul-Aug;14(4A):1557-62. Anticancer Res. 1994. PMID: 7979185

10

Ubenimex treatment enhances the susceptibility of gastric cancer cell lines to lymphokine-activated killer cells.

Iwahashi M, Tanimura H, Yamaue H, Tani M, Noguchi K, Mizobata S, Tsunoda T, Tamai M, Hotta T, Arii K, et al. Iwahashi M, et al. Among authors: arii k. Anticancer Res. 1994 Jul-Aug;14(4A):1563-8. Anticancer Res. 1994. PMID: 7979186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters